A panelist discusses how polycythemia vera (PV) symptoms can vary significantly among patients, but commonly include headaches, dizziness, itching (especially after warm baths), fatigue and visual ...

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...

While treatment options may be fairly straightforward for high-risk patients with polycythemia vera, it’s less clear for patients who are considered low risk, explained Jennifer Vaughn, MD. Patients ...

Rusfertide may eliminate therapeutic phlebotomies in polycythemia vera, showing symptomatic improvement and potential treatment utility. Besremi outperformed anagrelide in essential thrombocythemia, ...

For patients with a rare type of blood cancer, treatment might finally be coming out of the Dark Ages. People with the chronic condition polycythemia vera make too many red blood cells, thickening ...

In part 3 of a discussion with Andrew Kuykendall, MD, Moffitt Cancer Center, he talks of rusfertide’s ability to enable patients to live a more viable life and free them from being tethered to the ...

In patients with renal insufficiency associated with increased hemoglobin levels and polycythemia, the possibilities of recombinant erythropoietin overdosing and disorders such as neoplasms and ...

MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with ...

Breakthrough designation for rusfertide was supported by positive 32-week data from the Phase 3 VERIFY study, which was presented as a late breaking abstract highlighting its practice-changing ...